Acne scarring - Reviewing the need for early treatment of acne

Journal of Dermatological Treatment

Volumn 11, Issue 1, 2000, Pages 3-6

  Layton, Alison M ^a  

^a HARROGATE DISTRICT HOSPITAL   (United Kingdom)

Author keywords

Acne; Acne scarring; Psychosocial disability; Qualify of life

Indexed keywords

ANTI ACNE AGENT; ISOTRETINOIN;

ACNE; CLINICAL TRIAL; DEPRESSION; DRUG EFFICACY; HUMAN; PATIENT SATISFACTION; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; PSYCHOSOCIAL DISORDER; QUESTIONNAIRE; REVIEW; SCAR FORMATION; SUICIDE;

EID: 0034020547     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.1080/095466300750163708     Document Type: Review

References (24)

1. Liveneh H, On the origins of negative attitudes towards people with disabilities. Rehab Literature (1982) 43: 338-47.
2. Sulzberger MB, Zaidens SH, Psychogenic factors in dermatologic disorder. Med Clin North Am (1948) 32: 669-72.
3. Kenyon FE, Psychosomatic aspects of acne. Br J Dermatol (1966) 78: 344-51.
4. Schuster S, Fisher GH, Harris E et al, The effect of skin disease on self image. Br J Dermatol (1978) 99 (Suppl 16): 18-19.
5. van der Meeran HM, van der Schaar WW, van der Hub CM, The psychological impact of severe acne. Cutis (1985) 36: 84-6.
6. Rubinov DR, Reduced anxiety and depression in cystic acne patients after successful treatment with oral isotretinoin. J Am Acad Dermatol (1987) 17: 25-32.
7. Jowett S, Ryan T, Skin disease and handicap. An analysis of the impact of skin. Soc Sci Med (1985 )20: 425-9.
8. Cunliffe WJ, Unemployment and acne. Br J Dermatol (1986) 115: 386.
9. World Health Organization, International classification of impairments, disabilities and handicaps. Geneva: WHO. 1980, pp. 27-8.
10. Finlay AY, Khan G, Dermatology Life Quality Index (DLQI) - a simple practical measure for routine clinical use. Clin Exp Dermatol (1994) 19: 210-16.
11. Motley RH, Finlay AY, How much disability is caused by acne? Clin Dermatol (1989) 14: 194-8.
12. Ware JE, The MOS 36-Item Short-Form Health Survey (SF-36). 1. Conceptual framework and item selection. Med Care (1992) 30: 437-83.
13. Malon E, Newton JN, Wassen A, Standard patient assessed quality of life instruments can be used to measure the benefits of acne treatment. Br J Dermatol (1995) 133 (suppl 45): 35.
14. Koo JYH, Smith LL, Psychological aspects of acne. Paed Dermatol (1991) 8: 185-8.
15. Simpson N, Effects of isotretinoin on quality of life in patients with acne. Pharmaco-Economics (1994) 6: 108-13.
16. Salek MS, Khan GK, Finlay AY, Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual life Res (1996) 5: 131-8.
17. Lewis-Jones MS, Finlay AY, The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol (1995) 132: 942-9.
18. Motley RJ, Finlay AY, Practical use of a disability index in the routine management of acne. Clin Exp Dermatol (1992) 17: 1-3.
19. Layton AM, Seukeran D, Cunliffe WJ, Scarred for Life? Dermatology (1997) 195 (Suppl 1): 15-21.
20. Clark SM, Goulden V, Finlay AY et al, The psychological and social impact of acne: a comparison study using three acne disability questionnaires. Br J Dermatol (1997) 137 (Suppl 50): 41.
21. Burke BM, Cunliffe WJ, The assessment of acne vulgaris. The Leeds Technique. Br J Dermatol (1984) 111: 83-93.
22. Kellet S, Gawkrodger SJ, The psychological and emotional impact of chronic acne and the effect of treatment with isotretinoin. Br J Dermatol (1998) 139 (Suppl 51): 56.
23. Layton AM, Henderson CA, Cunliffe WJ, A clinical evaluation of acne scarring and its incidence. Clin Exp Dermatol (1994) 19: 303-8.
24. Suekeran DC, Cunliffe WH, Islan J et al, The psychosocial impact of acne scarring. Br J Dermatol (1999) 141 (Suppl 55): 54.